» Articles » PMID: 22884903

Amyloid Precursor Protein (APP) Regulates Synaptic Structure and Function

Overview
Date 2012 Aug 14
PMID 22884903
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

The amyloid precursor protein (APP) plays a critical role in Alzheimer's disease (AD) pathogenesis. APP is proteolytically cleaved by β- and γ-secretases to generate the amyloid β-protein (Aβ), the core protein component of senile plaques in AD. It is also cleaved by α-secretase to release the large soluble APP (sAPP) luminal domain that has been shown to exhibit trophic properties. Increasing evidence points to the development of synaptic deficits and dendritic spine loss prior to deposition of amyloid in transgenic mouse models that overexpress APP and Aβ peptides. The consequence of loss of APP, however, is unsettled. In this study, we investigated whether APP itself plays a role in regulating synaptic structure and function using an APP knock-out (APP-/-) mouse model. We examined dendritic spines in primary cultures of hippocampal neurons and CA1 neurons of hippocampus from APP-/- mice. In the cultured neurons, there was a significant decrease (~35%) in spine density in neurons derived from APP-/- mice compared to littermate control neurons that were partially restored with sAPPα-conditioned medium. In APP-/- mice in vivo, spine numbers were also significantly reduced but by a smaller magnitude (~15%). Furthermore, apical dendritic length and dendritic arborization were markedly diminished in hippocampal neurons. These abnormalities in neuronal morphology were accompanied by reduction in long-term potentiation. Strikingly, all these changes in vivo were only seen in mice that were 12-15 months in age but not in younger animals. We propose that APP, specifically sAPP, is necessary for the maintenance of dendritic integrity in the hippocampus in an age-associated manner. Finally, these age-related changes may contribute to AD pathology independent of Aβ-mediated synaptic toxicity.

Citing Articles

Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP.

Zhang J, Jiang Y, Dong X, Meng Z, Ji L, Kang Y Alzheimers Res Ther. 2024; 16(1):160.

PMID: 39030577 PMC: 11264788. DOI: 10.1186/s13195-024-01527-3.


CNTN4 modulates neural elongation through interplay with APP.

Bamford R, Zuko A, Eve M, Sprengers J, Post H, Taggenbrock R Open Biol. 2024; 14(5):240018.

PMID: 38745463 PMC: 11293442. DOI: 10.1098/rsob.240018.


Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways.

Coronel R, Bernabeu-Zornoza A, Palmer C, Gonzalez-Sastre R, Rosca A, Mateos-Martinez P Int J Mol Sci. 2023; 24(16).

PMID: 37629148 PMC: 10455174. DOI: 10.3390/ijms241612964.


APP family member dimeric complexes are formed predominantly in synaptic compartments.

Schilling S, August A, Meleux M, Conradt C, Tremmel L, Teigler S Cell Biosci. 2023; 13(1):141.

PMID: 37533067 PMC: 10398996. DOI: 10.1186/s13578-023-01092-6.


Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease.

Chen J, Chen J, Li S, Zhang F, Deng J, Zeng L Aging Dis. 2023; 15(1):201-225.

PMID: 37307834 PMC: 10796103. DOI: 10.14336/AD.2023.0308.


References
1.
Konietzko U . AICD nuclear signaling and its possible contribution to Alzheimer's disease. Curr Alzheimer Res. 2011; 9(2):200-16. DOI: 10.2174/156720512799361673. View

2.
Barbagallo A, Wang Z, Zheng H, DAdamio L . A single tyrosine residue in the amyloid precursor protein intracellular domain is essential for developmental function. J Biol Chem. 2011; 286(11):8717-21. PMC: 3059018. DOI: 10.1074/jbc.C111.219873. View

3.
Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

4.
Russo T, Faraonio R, Minopoli G, de Candia P, De Renzis S, Zambrano N . Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's beta-amyloid precursor protein. FEBS Lett. 1998; 434(1-2):1-7. DOI: 10.1016/s0014-5793(98)00941-7. View

5.
Bittner T, Fuhrmann M, Burgold S, Jung C, Volbracht C, Steiner H . Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci. 2009; 29(33):10405-9. PMC: 6665795. DOI: 10.1523/JNEUROSCI.2288-09.2009. View